CNBCLean R·
The startup using AI to help rare disease families develop custom treatments
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
Read at CNBC →
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
<iframe src="https://statesidedaily.com/embed/cluster/2a78d597e7a47ce8d66b1d10562b7ae1229d0e93" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="The startup using AI to help rare disease families develop custom treatments"></iframe>